To the full analysis
Buyback calculator for Alkem Laboratories
Alkem Laboratories stock: key metrics
ALKEM.NSAlkem Laboratories had an operating margin of 17.8% and a return on invested capital (ROIC) of 19.2% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2010 | 54.7% | 14.6% | 17.5% |
| 2011 | 56.9% | 17.1% | 19.6% |
| 2012 | 57.4% | 19.7% | 22.2% |
| 2013 | 58.8% | 18.8% | 21.8% |
| 2014 | 53.2% | 13.3% | 14.3% |
| 2015 | 52.5% | 10.1% | 10.5% |
| 2016 | 57.9% | 15.9% | 15.2% |
| 2017 | 58.6% | 16.2% | 15.9% |
| 2018 | 60.5% | 14.2% | 10.0% |
| 2019 | 57.6% | 13.0% | 10.5% |
| 2020 | 57.8% | 15.5% | 13.8% |
| 2021 | 58.9% | 19.1% | 18.2% |
| 2022 | 59.3% | 16.8% | 15.7% |
| 2023 | 56.4% | 11.7% | 8.6% |
| 2024 | 59.5% | 16.0% | 14.4% |
| 2025 | 62.1% | 17.1% | 16.9% |
| 2026 | 65.4% | 17.8% | 15.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2010 | 19.5% | 30.6% | 15.1% |
| 2011 | 22.7% | 29.7% | 12.5% |
| 2012 | 22.3% | 29.5% | 13.4% |
| 2013 | 20.9% | 20.1% | 12.3% |
| 2014 | 16.5% | 12.7% | 10.1% |
| 2015 | 13.1% | 9.4% | 7.4% |
| 2016 | 20.1% | 16.6% | 13.4% |
| 2017 | 20.0% | 20.0% | 13.6% |
| 2018 | 13.0% | 12.8% | 8.2% |
| 2019 | 14.0% | 14.1% | 9.3% |
| 2020 | 18.3% | 17.4% | 11.3% |
| 2021 | 21.5% | 19.5% | 13.8% |
| 2022 | 19.1% | 18.1% | 11.7% |
| 2023 | 10.9% | 10.4% | 7.2% |
| 2024 | 17.4% | 20.3% | 11.5% |
| 2025 | 18.1% | 21.4% | 12.2% |
| 2026 | 16.7% | 19.2% | 11.0% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ₹94.0836)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 25 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.